NM

Neelam Maini

Director Director DIN 03036901
DIN 03036901 First appointment May 2010 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since May 2010
Shareholding value Locked Premium profile

About Neelam Maini

Neelam Maini has 16 years in corporate governance. Formerly with 1 company, such as Sacro Sanct Drugs Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 03036901
Primary Designation Director
First Appointment 06 May 2010
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Sacro Sanct Drugs Private Limited U51109GJ2010PTC060557
Director 06 May 2010 2010 Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sacro Sanct Drugs Private Limited
Premium access

Shareholding and investment profile for Neelam Maini

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Neelam Maini

Neelam Maini has 16 years in corporate governance. Formerly with 1 company, such as Sacro Sanct Drugs Private Limited. Engaged in General Business. Contributes to corporate operations.

Neelam Maini is associated with 0 companies as a director.

Neelam Maini has expertise in General Business.

Neelam Maini has 16 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available